| Clifford Blaylock, CRNA | |
|
208 Rachelle Dr, Oxford, MS 38655-6135 | |
| (662) 281-8700 | |
| Not Available |
| Full Name | Clifford Blaylock |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 28 Years |
| Location | 208 Rachelle Dr, Oxford, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043259146 | NPI | - | NPPES |
| 00119446 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R782755 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rayner Eye Clinic, Llc | 9537136577 | 10 |
News Archive
The American Association for Cancer Research will recognize Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
Blue Cross and Blue Shield of Illinois announces four new, strategic agreements aimed at improving patient care while slowing health care cost trends. Accountable Care Organizations are a value-based care model that seeks to move the healthcare industry's payment structure from one based on fee-for-service, or volume, to one that reimburses based on the quality of patient outcomes and patient care. In an ACO, both the payer and provider share financial risk, and in return, shared savings, while improving the care that is delivered.
Pharmacy benefit management companies, the third-party administrators for prescription drug programs, have seen a boom in business. NPR reports they are "now poised for even more growth, as baby boomers age and Congress prepares to insure more Americans. ..."
Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.
› Verified 4 days ago
| Entity Name | Rayner Eye Clinic, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326148578 PECOS PAC ID: 9537136577 Enrollment ID: O20040910000538 |
News Archive
The American Association for Cancer Research will recognize Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
Blue Cross and Blue Shield of Illinois announces four new, strategic agreements aimed at improving patient care while slowing health care cost trends. Accountable Care Organizations are a value-based care model that seeks to move the healthcare industry's payment structure from one based on fee-for-service, or volume, to one that reimburses based on the quality of patient outcomes and patient care. In an ACO, both the payer and provider share financial risk, and in return, shared savings, while improving the care that is delivered.
Pharmacy benefit management companies, the third-party administrators for prescription drug programs, have seen a boom in business. NPR reports they are "now poised for even more growth, as baby boomers age and Congress prepares to insure more Americans. ..."
Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clifford Blaylock, CRNA 208 Rachelle Dr, Oxford, MS 38655-6135 Ph: (662) 281-8700 | Clifford Blaylock, CRNA 208 Rachelle Dr, Oxford, MS 38655-6135 Ph: (662) 281-8700 |
News Archive
The American Association for Cancer Research will recognize Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
Blue Cross and Blue Shield of Illinois announces four new, strategic agreements aimed at improving patient care while slowing health care cost trends. Accountable Care Organizations are a value-based care model that seeks to move the healthcare industry's payment structure from one based on fee-for-service, or volume, to one that reimburses based on the quality of patient outcomes and patient care. In an ACO, both the payer and provider share financial risk, and in return, shared savings, while improving the care that is delivered.
Pharmacy benefit management companies, the third-party administrators for prescription drug programs, have seen a boom in business. NPR reports they are "now poised for even more growth, as baby boomers age and Congress prepares to insure more Americans. ..."
Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.
Wyeth Pharmaceuticals has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the ReFacto Antihemophilic Factor (Recombinant) R2 Kit, the first needle-less reconstitution device with a prefilled diluent syringe for hemophilia.
› Verified 4 days ago
Julie Y. Fernanadez, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2301 South Lamar Blvd., Oxford, MS 38655 Phone: 662-232-8100 Fax: 334-244-1830 | |
Penneye Holder, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1208 Office Park Dr, Oxford, MS 38655 Phone: 662-234-9888 | |
Kevin Bowden, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1100 Belk Blvd, Oxford, MS 38655 Phone: 662-377-4394 | |
Lori Gray, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2704 W Oxford Loop Ste 117, Oxford, MS 38655 Phone: 662-550-4299 Fax: 662-580-4324 | |
Bradley Bailey, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2301 S Lamar Blvd, Oxford, MS 38655 Phone: 662-232-8100 | |
Mrs. Laura Nicole Billingsley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 144 Downing St, Oxford, MS 38655 Phone: 662-501-0119 |